Abstract
Backgroundankylosing spondylitis (AS), like the other chronic inflammatory rheumatic diseases, is considered to have higher cardiovascular (CV) risk (1). The Etiopathogenesis is not clearly defined.Objectivesassess the early biological markers of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
